Show simple item record

dc.contributor.authorLinden, Matthew Dean
dc.contributor.authorFrelinger, Andrew L. III
dc.contributor.authorBarnard, Marc R.
dc.contributor.authorPrzyklenk, Karin
dc.contributor.authorFurman, Mark I.
dc.contributor.authorMichelson, Alan D.
dc.date2022-08-11T08:10:10.000
dc.date.accessioned2022-08-23T16:58:30Z
dc.date.available2022-08-23T16:58:30Z
dc.date.issued2004-10-01
dc.date.submitted2012-04-25
dc.identifier.citationSemin Thromb Hemost. 2004 Oct;30(5):501-11. doi 10.1055/s-2004-835671
dc.identifier.issn0094-6176 (Linking)
dc.identifier.doi10.1055/s-2004-835671
dc.identifier.pmid15497093
dc.identifier.urihttp://hdl.handle.net/20.500.14038/43381
dc.description.abstractFlow cytometry is a powerful and versatile tool that can be used to yield definitive information regarding the phenotypic status of platelets. The method provides a quantitative assessment of the physical and antigenic properties of platelets (e.g., surface expression of receptors, bound ligands, components of granules, or interactions of platelets with other platelets, other blood cells, or components of the plasma coagulation system), thereby facilitating the diagnosis of inherited or acquired platelet disorders (e.g., Bernard-Soulier syndrome, Glanzmann thrombasthenia, storage pool disease), the pathological activation of platelets (e.g., in the setting of acute coronary syndromes, cerebrovascular ischemia, peripheral vascular disease, cardiopulmonary bypass), and changes in the ability of platelets to activate via specific stimuli (e.g., efficacy of antiplatelet therapies). Accordingly, this review summarizes the key technical and methodologic components of flow cytometric analysis of platelets, as well as specific examples of its application to diagnosis and patient care.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15497093&dopt=Abstract">Link to article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1055/s-2004-835671
dc.subjectBlood Platelet Disorders
dc.subjectBlood Platelets
dc.subjectCoronary Disease
dc.subjectFlow Cytometry
dc.subjectHumans
dc.subjectPhenotype
dc.subjectPlatelet Activation
dc.subjectSyndrome
dc.subjectThrombocytopenia
dc.subjectHematology
dc.subjectOncology
dc.subjectPediatrics
dc.titleApplication of flow cytometry to platelet disorders
dc.typeJournal Article
dc.source.journaltitleSeminars in thrombosis and hemostasis
dc.source.volume30
dc.source.issue5
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/peds_hematology/59
dc.identifier.contextkey2796549
html.description.abstract<p>Flow cytometry is a powerful and versatile tool that can be used to yield definitive information regarding the phenotypic status of platelets. The method provides a quantitative assessment of the physical and antigenic properties of platelets (e.g., surface expression of receptors, bound ligands, components of granules, or interactions of platelets with other platelets, other blood cells, or components of the plasma coagulation system), thereby facilitating the diagnosis of inherited or acquired platelet disorders (e.g., Bernard-Soulier syndrome, Glanzmann thrombasthenia, storage pool disease), the pathological activation of platelets (e.g., in the setting of acute coronary syndromes, cerebrovascular ischemia, peripheral vascular disease, cardiopulmonary bypass), and changes in the ability of platelets to activate via specific stimuli (e.g., efficacy of antiplatelet therapies). Accordingly, this review summarizes the key technical and methodologic components of flow cytometric analysis of platelets, as well as specific examples of its application to diagnosis and patient care.</p>
dc.identifier.submissionpathpeds_hematology/59
dc.contributor.departmentDepartment of Anesthesiology
dc.contributor.departmentDepartment of Emergency Medicine
dc.contributor.departmentDepartment of Pediatrics
dc.source.pages501-11


This item appears in the following Collection(s)

Show simple item record